| Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death AA Kapralov, Q Yang, HH Dar, YY Tyurina, TS Anthonymuthu, R Kim, ... Nature chemical biology 16 (3), 278-290, 2020 | 395 | 2020 |
| Ferroptosis of tumour neutrophils causes immune suppression in cancer R Kim, A Hashimoto, N Markosyan, VA Tyurin, YY Tyurina, G Kar, S Fu, ... Nature 612 (7939), 338-346, 2022 | 197 | 2022 |
| Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins N Cuburu, S Khan, CD Thompson, R Kim, J Vellinga, R Zahn, DR Lowy, ... International journal of cancer 142 (7), 1467-1479, 2018 | 43 | 2018 |
| A prime-pull-amplify vaccination strategy to maximize induction of circulating and genital-resident intraepithelial CD8+ memory T cells N Çuburu, R Kim, GC Guittard, CD Thompson, PM Day, DE Hamm, ... The Journal of Immunology 202 (4), 1250-1264, 2019 | 38 | 2019 |
| Ferroptosis of immune cells in the tumor microenvironment R Kim, D Taylor, RH Vonderheide, DI Gabrilovich Trends in Pharmacological Sciences 44 (8), 542-552, 2023 | 25 | 2023 |
| Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors N Çuburu, L Bialkowski, SM Pontejo, SK Sethi, ATF Bell, R Kim, ... Proceedings of the National Academy of Sciences 119 (26), e2116738119, 2022 | 23 | 2022 |
| Isolation and phenotyping of splenic myeloid-derived suppressor cells in murine cancer models E Sanseviero, R Kim, DI Gabrilovich Myeloid-Derived Suppressor Cells, 19-28, 2021 | 6 | 2021 |
| Harnessing pre-existing anti-viral immunity for tumor therapy C Nicolas, L Bialkowski, S Pontejo, R Kim, A Bell, C Thompson, D Lowy, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 4 | 2019 |
| Harnessing pre-existing viral immunity for development of a broadly applicable tumor immunotherapy N Cuburu, L Bialkowski, SM Pontejo, A Bell, R Kim, CD Thompson, ... Cancer Research 80 (16_Supplement), 5563-5563, 2020 | 1 | 2020 |
| Polymorphonuclear myeloid derived suppressor cells die by ferroptosis in the tumor microenvironment. R Kim, A Hashimoto, N Markosyan, VA Tyurin, YY Tyurina, S Fu, ... CANCER RESEARCH 82 (22), 142-143, 2022 | | 2022 |
| Abstract C046: Polymorphonuclear myeloid derived suppressor cells die by ferroptosis in the tumor microenvironment R Kim, A Hashimoto, N Markosyan, VA Tyurin, YY Tyurina, S Fu, ... Cancer Research 82 (22_Supplement), C046-C046, 2022 | | 2022 |
| INAUGURAL ARTICLE by a Recently Elected Academy Member: Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors N Çuburu, L Bialkowski, SM Pontejo, SK Sethi, ATF Bell, R Kim, ... Proceedings of the National Academy of Sciences of the United States of …, 2022 | | 2022 |
| Harnessing pre-existing antiviral immunity to treat solid tumors N Cuburu, R Kim, S Pontejo, C Thompson, D Lowy, J Schiller JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017 | | 2017 |
Dmitry GabrilovichChief Scientist, Cancer Immunology, AstraZeneca在 astrazeneca.com 的电子邮件经过验证
